search for
or search by
Results 1 - 20 of 346
Science-Based Games & Books for Children Demystifies Intimidating Concepts
Genius Games is a publishing company that focuses science-based games, children's books, and toys. We have sold science-based products to over 50 countries globally, with currently four tabletop games and three children's books under our belt.
Ascendia Pharmaceuticals Announces Issuance of New Patent for Acute Coronary Syndrome Program
Ascendia Pharmaceuticals, a specialty pharmaceutical company engaged in nano-formulation design, development, and manufacture for poorly soluble molecules, recently announced it has been awarded a new patent.
Pfizer CentreOne Expands Fill-Finish Services
Pfizer CentreOne, a global contract manufacturing organization embedded within Pfizer, recently announced that it has expanded its fill-finish services to its Kalamazoo, MI, site.
Metrics Contract Services: Your "Concept to Commercialization" Partner
The parent company of Metrics Contract Services, Mayne Pharma, is investing $80 million to significantly expand facilities and equipment at its site in Greenville, N.C.
Foster Delivery Science & ProMed Pharma Partner
Foster Delivery Science and ProMed Pharma have entered into a commercial partnership to provide comprehensive contract services for pharmaceutical and combination device applications.
Pharma & Biotech: 2017 Review of Outsourced Manufacturing
Based on our analysis, the outsourced manufacturing sector is a fertile ground for investment, based on the growth prospects above expected GDP growth and the sub-sectors that can excel in the sector. Industry M&A trends over the last decade have transformed the outsourced manufacturing sector with some significant players emerging.
Next-Generation Silicone Adhesive Technologies Key to Broader Global Adoption, Growth of Wearable Medical Devices
Dow Corning, a global leader in silicones, silicon-based technology, and innovation and a wholly owned subsidiary of The Dow Chemical Company, sees the role of specialized adhesive technologies as a key driver of this growth – especially in skin-adhered medical devices, a major segment of the wearables market.
SiO2 Medical Products, Inc. Receives Marketing Authorization for Filled 6-mL Vials
SiO2 Medical Products, Inc. (SMP) received marketing authorization (MA) for the Type II variation of the primary packaging of zoledronic acid from the German Medicines Authority BfArM on November 25, 2016. The drug, zoledronic acid, is packaged in a proprietary 6-mL vial developed by SMP.
Patheon Announces Completion of its Acquisition of State-of-the-Art Manufacturing Site
Patheon N.V, a leading global provider of high-quality drug development and delivery solutions to the pharmaceutical and biopharma sectors, announced that it has completed the acquisition of a state-of-the-art manufacturing facility in Florence, SC, from Roche Holdings, Inc. Patheon has begun integrating the site into the Patheon network.
West Introduces LyoSeal® Instant Sealing Solution & NovaGuard® SA Pro Safety System
West Pharmaceutical Services, Inc., a global leader in innovative solutions for injectable drug administration, recently introduced two new offerings at Pharmapack Europe 2017.
Ompi Presents its Integrated Needlestick Protection
Ompi expands its Ompi EZ-fill® Syringes offer by adding up an Integrated Safety System (ISS) for staked needle syringes. Ompi EZ-fill® ISS is a brand new fully passive safety system designed to guarantee end users’ safety and reduce total cost of ownership for the pharmaceutical companies.
Terumo & Nemera Announce Validated Compatibility Between PLAJEX Polymer Prefillable Syringes & Safe'n'Sound
To serve the needs of the pharmaceutical industry and users, Nemera and Terumo agreed to cooperate to confirm compatibility between PLAJEXTM COP prefillable syringes and the Safe’n’Sound® platform, an add-on passive sharps injury protection device for prefilled syringes (PFS).
Mikron Automation Expands US Headquarters in Metro Denver
Mikron Automation and Denver-based Confluent Development are pleased to announce the expansion of Mikron Automation’s U.S. headquarters in Arapahoe County’s Dove Valley Business Park.
Antibacterial Drugs Market Will Hit $35.6 Billion by 2022
The antibacterial drugs market is set to grow from $27.7 billion in 2015 to $35.6 billion by 2022, representing a compound annual growth rate of 3.97%, according to business intelligence provider GBI Research.
Elemental Impurities: Implications for Manufacturers of Drug Products, APIs & Excipients
The International Conference on Harmonization (ICH) finalized the ICH Q3D Guideline for elemental impurities in December 2014.1 Regulators are now implementing the requirements worldwide, with some start dates already in place as of June 2016.
Avomeen Recapitalizes to Achieve Next Growth Plan Objective
In an effort to foster growth and reinforce its infrastructure, Avomeen Analytical Services, a fast growing full-service independent analytical and chemical testing laboratory based in Ann Arbor, MI, recently announced a recapitalization with High Street Capital, a Chicago-based provider of flexible capital and operating expertise to middle market businesses.
Gerresheimer Introduces Metal-Free Syringe
Biopharmaceuticals demonstrate a series of special features. They are often highly viscous and in individual cases tend to interact with silicone oil or, for example, tungsten residue from syringe production..........
PCI Clinical Services & Suvoda Announce Strategic Partnership
PCI Clinical Services recently announced a partnership with Suvoda LLC that will benefit clinical trials, delivering Suvoda’s cutting-edge IRT/IWRS technology for subject randomization and trial supply management integrated with PCI’s comprehensive packaging and logistical services for clinical trial supplies.
Nemus Bioscience Announces Licensing Agreement for a Cannabinoid-Based Anti-Infective Platform Directed Against Drug-Resistant Organisms
NEMUS Bioscience, Inc. (NMUS) announced that the company had signed a licensing agreement with the University of Mississippi (UM) for a platform of cannabinoid-based molecules (UM5070) for potential anti-infective use against bacteria, viruses, and fungi.
Catalent to Develop Softgel Capsules for JOT's Leading Orphan Disease Candidates
Catalent Pharma Solutions recently announced that it is to evaluate Jupiter Orphan Therapeutics, Inc.’s (JOT) novel formulation of resveratrol, JOTROL, for delivery using Catalent’s R.P. Scherer softgel technology.


Click here to see the showcases

March 21-23
New York, NY

PDA Annual Meeting
April 3-5
Anaheim, CA

RDD (Respiratory Drug Delivery)
April 25-28
Nice, France

Pre-filled Syringes East Coast
April 26-27
Boston, MA

AAPS National Biotechnology Meeting
May 1-3
San Diego, CA

Innovation Networking Summit & Table-top Exhibition
May 4-5
Hilton Hotel, Parsippany, NJ

CPhI North America & Informex
May 16-18
2017 Philadelphia, PA

BIO 2017
June 19 - 22
San Diego, CA

Controlled Release Society Meeting
July 16-19 Boston, MA

CPhI Worldwide
October 24-26
Frankfurt, Germany

Universe of Prefilled Syringes & Injection Devices Europe
November 7-8
Nienna, Austria

November 12-17
San Diego, CA


Copyright © 2017  Drug Development & Delivery All Rights Reserved. Privacy Policy / Terms and Conditions